1. ScholarBank@NUS

XXX Folefac Aminkeng

rp62345

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
XXX Folefac Aminkeng
(not current staff)
Main Affiliation
 
Faculty
 
Email
mdcfa@nus.edu.sg
 

Publications

Refined By:
Subject:  Oncology

Results 1-10 of 10 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
11-Mar-2018An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclinesDionne, Francois; Aminkeng, Folefac ; Bhavsar, Amit P; Groeneweg, Gabriella; Smith, Anne ; Visscher, Henk; Rassekh, Shahrad Rod; Ross, Colin; Carleton, Bruce
21-Nov-2017Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular CancerDrogemoller, Britt I; Monzon, Jose G; Bhavsar, Amit P; Borrie, Adrienne E; Brooks, Beth; Wright, Galen EB; Liu, Geoffrey; Renouf, Daniel J; Kollmannsberger, Christian K; Bedard, Philippe L; Aminkeng, Folefac ; Amstutz, Ursula; Hildebrand, Claudette A; Gunaretnam, Erandika P; Critchley, Carol; Chen, Zhuo; Brunham, Liam R; Hayden, Michael R; Ross, Colin JD; Gelmon, Karen A; Carleton, Bruce C
31-Feb-2019CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelinesDrogemoller, Britt I; Wright, Galen EB; Shih, Joanne; Monzon, Jose G; Gelmon, Karen A; Ross, Colin JD; Amstutz, Ursula; Carleton, Bruce C; Chang, Wan C; Connolly, Mary B; Dionne, Francois; Groeneweg, Gabriella; Loucks, Catrina M; MacLeod, Stuart M; Pritchard, Sheila; Rassekh, Shahrad R; Sanatani, Shubhayan; Bhavsar, Amit P; Rieder, Michael J; Shear, Neil H; Ito, Shinya; Liu, Geoffrey; Khayat, Philip; Bernstein, Daniel; Lesko, Lawrence J; Aminkeng, Folefac 
4Sep-2022Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Asian Patients with Advanced NSCLCHuang, Y; Zhao, JJ; Soon, YY; Kee, A; Tay, SH; Aminkeng, F ; Ang, Y; Wong, A; Goh, BC; Soo, R 
512-May-2023Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerHuang, Yiqing; Zhao, Joseph J; Soon, Yu Yang; Kee, Adrian; Tay, Sen Hee; Aminkeng, Folefac ; Ang, Yvonne; Wong, Alvin SC; Bharwani, Lavina D; Goh, Boon Cher; Soo, Ross A 
61-Mar-2021Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control StudyLee, Pei Yi; Oen, Kellynn Qi Xuan; Lim, Grace Rui Si; JUANDA LEO HARTONO ; MARK DHINESH MUTHIAH ; Huang, Daniel Q; Teo, Felicia Su Wei; LI YUNKAI ANDREW ; Mak, A. ; Chandran, Nisha Suyien; CHRIS TAN LIXIAN ; Yang, Peiling; Tai, E.S. ; Ng, Kay Wei Ping; JOY VIJAYAN ; Chan, Yee Cheun; TAN LI LING ; LEE BENG HUAT, MARTIN ; Chua, Horng Ruey; HONG WEI ZHEN ; YAP ENG SOO ; Lim, Dawn K; YUEN YEW SEN ; Chan, Y.H. ; FOLEFAC AMINKENG ; Wong, Alvin Seng Cheong; Huang, Yiqing; TAY SEN HEE 
71-Jun-2022Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patientsHuang, Yiqing; Aminkeng, Folefac ; Wong, Alvin SC; Tay, Sen Hee ; Zhao, Joseph J; Ang, Yvonne; Soo, Ross A ; Goh, Boon Cher 
830-Sep-2022Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancerHuang, Yiqing; Zhao, Joseph J; Soon, Yu Yang ; Wong, Alvin; Aminkeng, Folefac ; Ang, Yvonne; Asokumaran, Yugarajah; Low, Jia Li; Lee, Matilda; Choo, Joan RE; Chan, Gloria; Kee, Adrian ; Tay, Sen Hee ; Goh, Boon Cher ; Soo, Ross A 
913-Oct-2021Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patientsHuang, Yiqing; Soon, Yu Yang ; Aminkeng, Folefac ; Tay, Sen Hee ; Ang, Yvonne; Kee, Adrian CL ; Goh, Boon Cher ; Wong, Alvin SC; Soo, Ross A 
10Mar-2021Risk Factors for Immune-Related Adverse Events from Anti-PD-1/PD-L1 Treatment in an Asian Cohort of NSCLC PatientsHuang, Y; Soon, YY; Aminkeng, F ; Tay, SH; Ang, Y; Goh, BC; Wong, A; Soo, RA